Results of a retrospective study demonstrated that retreatment with ICIs after severe immune-related adverse events could result in good response for select patients.

Bemarituzumab targets FGFR2b, which has been found to be overexpressed in approximately 30% of patients with non-HER2 positive gastric cancer.

Data from clinical trials have indicated that PSA is prognostic for outcomes, but little is known about real-world trends.

Our large observational study adds long-term survival to the mounting data supporting the use and safety of conservative surgery for low-risk, early-stage cervical carcinoma,” the researchers wrote.

Although treatment with high-dose corticosteroids can reduce mast burden and improve symptoms such as pain, congestive heart failure, and cytopenia in patients with MCL, their effects are frequently ...

Decision-making was influenced by patient values and did not vary by stage, race and ethnicity, or demographics.

Researchers evaluated an electronic health record-based intervention that identified patients with metastatic cancer for a multipronged approach to their in-hospital care.